Immunology markers that can be predictive for the diagnosis of juvenile idiopathic arthritis

Author:

Sur Lucia M.12,Silaghi Ciprian3,Colceriu Marius C.45,Sur Daniel G.6,Aldea Cornel5,Sur Genel45,Floca Emanuela78,Tataru Alexandru9,Lupan Iulia10,Samasca Gabriel1112ORCID

Affiliation:

1. “Iuliu Hatieganu” University of Medicine and Pharmacy , Department of Pediatrics I , Cluj-Napoca , Romania

2. Emergency Clinical Hospital for Children , Pediatrics I Department , Cluj-Napoca , Romania

3. “Iuliu Hatieganu” University of Medicine and Pharmacy , Department of Biochemistry , Cluj-Napoca , Romania

4. “Iuliu Hatieganu” University of Medicine and Pharmacy , Department of Pediatrics II , Cluj-Napoca , Romania

5. Emergency Clinical Hospital for Children , Pediatrics II Department , Cluj-Napoca , Romania

6. The Oncology Institute “Prof. Dr. Ion Chiricuţă” Cluj-Napoca , Cluj-Napoca , Romania

7. “Iuliu Hatieganu” University of Medicine and Pharmacy , Department of Immunology and Allergology , Cluj-Napoca , Romania

8. Regional Institute of Gastroenterology and Hepatology “Octavian Fodor” Cluj-Napoca, Cluj-Napoca , Romania

9. Dermatology Clinical Hospital , Cluj-Napoca , Romania

10. Babes Bolyai University , Cluj-Napoca , Romania

11. Emergency Clinical Hospital for Children , Medical Analysis Department , Cluj-Napoca , Romania

12. “Iuliu Hatieganu” University of Medicine and Pharmacy , Department of Immunology and Allergology , Cluj-Napoca, Cluj 400012 , Romania

Abstract

Abstract Background This study aimed to investigate the implications of antinuclear antibodies (ANAs) in juvenile idiopathic arthritis (JIA), the association with uveitis and the favorable evolution of the disease. Methods We followed 45 pediatric patients suffering from JIA, according to the International League of Associations for Rheumatology (ILAR), for a period of 2 years. ANAs were followed through immunofluorescence methods using a high-performance immunofluorescence automatic Helios device. Results A total of 15 of the ANA-positive patients presented an oligoarticular form of the disease, eight of them presented a polyarticular form of the disease and two of them presented a systemic form. The most severe forms have associated iridocyclitis. ANA-positive patients presented an earlier onset of disease in comparison with ANA-negative ones. ANA-positive patients from different ILAR categories had similar characteristics of the disease such as onset age (earlier), higher prevalence in females and the presence of asymmetric arthritis or iridocyclitis. Conclusions ANA may be an important marker for JIA and association with iridocyclitis. Following ANA titer in evolution might be a criterion for assessing the evolution of the disease. The association between positive ANA, oligoarticular JIA, iridocyclitis and a 2- to 4-year-old onset is common.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,Discrete Mathematics and Combinatorics

Reference13 articles.

1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767–78.

2. Antinuclear Antibodies (ANA) [Internet]. Rheumatology.org. 2018. Available at: https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Diseases-Conditions/Antinuclear-Antibodies-ANA.

3. Definition of Antinuclear Antibody. MedicineNet. 2018. Available at: https://www.medicinenet.com/script/main/art.asp?articlekey=6709.

4. UpToDate. Uptodate.com. 2018. Available at: https://www.uptodate.com/contents/antinuclear-antibodies-ana-beyond-the-basics.

5. Sur LM, Floca E, Sur D, Colceriu M, Samasca G, Sur G. Antinuclear antibodies: marker of diagnosis and evolution in autoimmune diseases. Lab Med 2018;17:840–1.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3